feed,title,long_url,short_url
Benzinga,CHMP Backs Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6 - 11 Years With Type 2 Inflammation,https://benzinga.com/general/biotech/22/01/25302536/chmp-backs-sanofi-regenerons-dupixent-for-asthma-patients-aged-6-11-years-with-type-2-inflammatio,https://bit.ly/3AORMSy
